Several Z-and E-methylenecyclopropane nucleoside analogues were synthesized and evaluated for antiviral activity. Reaction of the Z-and E-2amino-6-chloropurine methylenecyclopropanes with ammonia or cyclopropylamine gave 2,6diamino or 2-amino-6-cyclopropylamino analogues. Alkylation elimination of N 4 -acetylcytosine with ethyl Z-and E-2-bromo-2-bromomethylcyclopropane-1-carboxylates gave a mixture of the Zand E-methylenecyclopropane derivatives of cytosine. Reduction furnished a mixture of syncytol and the E isomer. Benzoylation led to the respective N 4 -benzoyl derivatives which were separated by chromatography. Debenzoylation afforded pure syncytol and the E isomer. Alkylation of 2,4bis-O-trimethylsilylthymine with ethyl Z-and E-2bromo-2-bromomethylcyclopropane-1-carboxylates gave the corresponding Z-and E-1-bromocyclopropylmethylderivatives of thymine. Basecatalysed elimination of HBr gave Z-and E-methylenecyclopropane carboxylic esters. Reduction furnished, after chromatographic separation, synthymol and the E isomer. The Z/E isomeric assignment of the obtained products followed from 1 H NMR spectroscopy. The methylenecyclopropane analogues were tested for antiviral activity in vitro against human and murine cytomegalovirus (HCMV, MCMV), Epstein-Barr virus (EBV), varicella zoster virus (VZV), hepatitis B virus (HBV), herpes simplex virus types 1 and 2 (HSV-1, HSV-2) , human herpesvirus 6 (HHV-6) and human immunodeficiency virus type 1 (HIV-1). The Z-2-amino-6-cyclopropylaminopurine analogue was the most effec-tive agent against HCMV (EC 50 or EC 90 0.4-2 µM) followed by syncytol and the Z-2,6-diaminopurine analogues (EC 50 or EC 90 3.4-29 and 11-24 µM, respectively). The latter compound was also a strong inhibitor of MCMV (EC 50 0.6 µM). Syncytol was the most potent against EBV (EC 50 <0.41 and 2.5 µM) followed by the Z-2,6-diaminopurine (EC 50 1.5 and 6.9 µM) and the Z-2-amino-6-cyclopropylaminopurine derivative (EC 50 11.8 µM). Syncytol was also most effective against VZV (EC 50 3.6 µM). Activity against HSV-1, HSV-2 and HHV-6 was generally lower; synthymol had an EC 50 of 2 µM against HSV-1 (ELISA) and 1.3 µM against EBV in Daudi cells but was inactive in other assays. The 2amino-6-cyclopropylamino analogue displayed EC 50 values between 215 and >74 µM in HSV-1 and HSV-2 assays. 2-Amino-6-cyclopropylaminopurine and 2,6-diaminopurine derivatives were effective against HBV (EC 50 2 and 10 µM, respectively), whereas none of the analogues inhibited HIV-1 at a higher virus load. Syncytol and the E isomer were equipotent against EBV in Daudi cells but the E isomer was much less effective in DNA hybridization assays. The E-2,6-diaminopurine analogue and E isomer of synthymol were devoid of antiviral activity.
In a previous report (Qiu et al., 1998) we described two new nucleoside analogues, synadenol 1 and synguanol 2 ( Fig. 1) which comprise a methylenecyclopropane moiety. Compounds 1 and 2 are particularly effective against human cytomegalovirus (HCMV) (EC 50 0.04-2.1 µM depending on the type of assay) as well as other herpesviruses and hepatitis B virus (HBV). Because 2amino-6-chloropurine derivative 3a also exhibited a strong anti-HCMV effect, it was of interest to study other purine methylenecyclopropane analogues. An investigation of the influence of substitution at position 6 on the antiviral activity seemed especially attractive. In addition, the question as to whether pyrimidine nucleoside analogues comprising a methylenecyclopropane moiety can provide new antiviral agents is also of significant importance.
We describe synthesis and biological asays of Z-and E-2,6-diaminopurine analogues 4a and 4b, Z-2-amino-6-cyclopropylaminopurine derivative 5 as well as Z-and E-cytosine and thymine analogues 6 (syncytol), 7, 8 (synthymol) and 9. [The designations syncytol and synthymol are extensions of the trivial names proposed previously (Qiu et al., 1998) for biologically active Z-methylenecyclopropane analogues synadenol and synguanol.] Whereas the selection of the 2,6-diaminopurine moiety in 4a and 4b follows a well-established rationale of other nucleoside analogues (Mitsuya et al., 1990) , the reasons for the design of methylenecyclopropane derivative 5 are less obvious. According to a recent report , the 2-amino-6-cyclopropylamino analogue 10a of another antiviral drug candidate, carbovir, exhibited potent anti-human immunodeficiency virus (HIV) activity. In addition, 2-amino-6-cyclopropylamino-9-(β-D-2′-deoxy-4′-thioribo-furanosyl)purine 10b is a strong inhibitor of replication of both HCMV and hepatitis B virus (HBV) (Van Draanen et al., 1996) . Our previous results (Qiu et al., 1998) , particularly the 1 H NMR spectra of the Z isomers such as synadenol 1 and synguanol 2, led us to believe that these methylenecyclopropane analogues would be better mimics of nucleoside structure than, for example, adenallene 11a or cytallene 11b (Fig.  2) , which are also potent antiviral agents (Zemlicka, 1993 (Zemlicka, , 1996 Zhu et al., 1997) . Therefore, compound 5 was also included in our study. Preliminary accounts of this work were reported previously (Qiu Y-L, Ksebati MB, Kern ER, Drach JC & Zemlicka J; Hydroxymethylcyclo-propylidenemethylpurines and -pyrimidines. 213th National Meeting of the American Chemical Society, San Francisco, California, April 13-17 1997, abstract MEDI 312; Qiu et al., 1997; Zemlicka et al., 1997) .
Materials and Methods: Chemistry

General Methods
Methods for synthesis and analysis have been described previously (Qiu et al., 1998) . The NMR spectra were determined in CD 3 SOCD 3 at 300 or 500 M Hz ( 1 H) unless stated otherwise. For IR spectra, KBr pellets were used and UV spectra were measured in ethanol. FAB mass spectra were recorded using a thioglycerol matrix. Starting materials 3a, 3b and 12 plus 13 were prepared as described previously (Qiu et al., 1998). (Z)-and (E)-2,6-diamino-9-(2-hydroxymethylcyclopropylidenemethyl)purine 4a and 4b A mixture of compound 3a (140 mg, 0.56 mmol) and NH 3 in MeOH (saturated at 0°C, 80 ml) was heated in a stainless steel bomb at 95°C (bath temperature) for 16 h. After cooling, the volatile components were evaporated and the residue was chromatographed on silica gel with CH 2 Cl 2 : MeOH (4 : 1) to give the title compound 4a ( OH, 18.5), 198 (10.8) , 173 (7.9), 163 (10.9), 159 (9.5), 150 (2,6-diaminopurine, 100.0); HRMS calcd for C 10 H 12 N 6 O: M 232.1072. Found: M 232.1076. Anal. calcd for C 10 H 12 N 6 O: C, 51.70; H, 5.21; N, 36.20. Found: C, 51.53; H, 5.35; N, 36.35 .
The E isomer 4b (343 mg, 93%) was obtained by the procedure described above and starting from 3b (400 mg O: C, 51.70; H, 5.21; N, 36.20. Found: C, 51.59; H, 5.38; N, 36.10. (Z)-2-amino-6-cyclopropylamino-9-(2-hydroxymethylcyclopropylidenemethyl)purine 5 A solution of compound 3a (151 mg, 0.60 mmol) and cyclopropylamine (0.416 ml, 6.0 mmol) in ethanol (15 ml) was refluxed for 24 h. After cooling, the volatile components were evaporated and the residue was chromatographed on silica gel with CH 2 Cl 2 : MeOH (95 : 5×9 : 1) to give the title compound 5 (156 mg, 95.5%). M.p. 190-193°C. UV λ max 285 nm (ε 16 000), 224 (ε 40 000); IR 3475, 3330 and 3200 (NH 2 and OH) and 1640-1595 (olefin and purine ring), 1043 cm -1 (cyclopropane ring); 1 H NMR δ 0.52-0.59 (m, 2H) and 0.63 (dt, 2H, 3 J 5.4 and 7.2 Hz, CH 2 of cyclopropylamino group), 1.14 (ddd, 1H, 2 13 H 16 N 6 O: C, 57.32; H, 5.93; N, 30.87. Found: C, 57.10; H, 6.07; N, 30.63. (Z)-1-(2-carbomethoxycyclopropylidenemethyl)cytosine 15 and (E)-1-(2-carbomethoxycyclopropylidenemethyl)cytosine 16
A mixture of N 4 -acetylcytosine (14, 3.37 g, 22 mmol), dibromoesters 12 and 13 (6.92 g, 24.2 mmol) and K 2 CO 3 (15.20 g, 110 mmol) was heated at 100°C (bath temperature) with stirring under N 2 for 3 h. The mixture was cooled to 50°C and methanol (10 ml) was added with stirring which was continued at 50°C for 1 h. The insoluble portion was filtered off using a Celite bed and the mixture was washed with CH 2 Cl 2 : MeOH (4 : 1, 3×30 ml). The filtrate was evaporated and the residue was chromatographed on a silica gel column (85 g) using CH 2 Cl 2 : MeOH (9 : 1) as an eluent to give a mixture of methyl esters 15 and 16 (2.28 g, 46.8%). Their ratio was 7 : 3 as determined by 1 , 54.28; H, 5.01; N, 19.00. Found: C, 54.56; H, 5.25; N, 18.79. The mother liquor was evaporated and the residue was recrystallized from ethanol to give a mixture of esters 15 and 16 (550 mg, 11.3%) in the ratio 1 : 2. M.p. 192-207°C. UV λ max 295 nm (ε 12 100), 230 nm (ε 11 500), 205 nm (ε 14 700); IR 3340 and 3100 (NH 2 ), 1750 (C=O, ester), 1670, 1635 and 1485 cm -1 (cytosine ring and olefin). E isomer 16: 1 
Reduction of Z and E esters 15 and 16 with diisobutyl aluminum hydride (DIBALH)
A solution of DIBALH in cyclohexane (1 M, 35.2 ml, 35.2 mmol) was added dropwise into a stirred suspension of a 1 : 2 mixture of esters 15 and 16 from the previous experiment (1.73 g, 7.82 mmol) in THF (230 ml) within 15 min at 0°C under N 2 . After 4 h, another portion of DIBALH (11.7 ml, 11.7 mmol) was added. The stirring was continued at 0°C for another 2 h. The reaction was quenched by adding MeOH : water (2 : 1, 30 ml) dropwise at 0°C. The mixture was then stirred overnight at room temperature. The gel-like solid was filtered off and washed with CH 2 Cl 2 : MeOH (1 : 1, 5×60 ml) with the aid of a sonicator. The combined filtrate and washings were evaporated to give a mixture of syncytol 6 and E isomer 7.
(Z)-and (E)-N 4 -benzoyl-1-(2-hydroxymethylcyclopropylidenemethyl)cytosine 18 and 19
The mixture of 6 and 7 from the previous experiment (7.82 mmol) was dissolved in refluxing ethanol (200 ml). Benzoic anhydride (1.77 g, 7.82 mmol) was added with stirring into a hot solution and the refluxing was continued for 1 h. Five more portions of benzoic anhydride (1.77 g, 7.82 mmol each) were added every hour. After cooling, the solvent was evaporated and the crude product was partitioned between CH 2 Cl 2 (150 ml) and saturated aqueous NaHCO 3 (150 ml). The aqueous phase was extracted with CH 2 Cl 2 (3×50 ml). The combined organic phases were washed with a mixture of saturated aqueous NaHCO 3 : saturated aqueous NaCl (1 : 3, 40 ml) and dried (Na 2 SO 4 ). After evaporation, the residue was chromatographed on a silica gel column using CH 2 Cl 2 : MeOH (98 : 2 and 95 : 5) to give O,N-dibenzoyl derivative 17 (625 mg, 20%), Z isomer 18 (480 mg, 20.7%) and E isomer 19 (960 mg, 41.4%). Both isomers were recrystallized from ethanol. Z isomer 18: M.p. 189-193°C. UV λ max 331 (ε 14 800), 270 (ε 19 200), 220 (ε 15 400), 206 (ε 17 200); IR 3370 (OH), 1695, 1665-1620, 1560 and 1490 (N 4 -benzoylcytosine and alkene), 1050 cm -1 (cyclopropane ring); 1 H NMR δ 1.15 (ddd, 1H, 2 J 8.5 Hz, 3 J trans 5.5 Hz, 4 J 2.0 Hz) and 1.41 (td, 1H, 2 J= 3 J cis =8.5 Hz, 4 J 1.5 Hz, H 3′ ), 2.14 (dqd, 1H, 3 J cis 8.0 Hz, 3 J trans 5.5, H 4′ ), 3.31 (dt, overlapped with H 2 O, 1H, 2 J 11.5 Hz, 3 J 6.5 Hz) and 3.65 (dt, 1H, 2 J 11.0 Hz, 3 J 6.0 Hz, H 5′ ), 5.01 (dd, 1H, 3 J 5.0 Hz, OH), 7.37 (s, overlapped with H 5 , 1H, 4 J 2.0 Hz, H 1′ ), 7.38 (d, overlapped with H 1′ , 1H, 3 J 7.5 Hz, H 5 ), 8.62 (d, 1H, 3 J 7.5 Hz, H 6 ), 11.30 (s, 1H, NH), 7.50 (t, 2H, 3 J 7.5 Hz, H meta ), 7.61 (t, 1H, 3 J 7.5 Hz, H para ) and 7.99 (d, 2H, 3 J 7.5 Hz, H ortho , C 6 H 5 CO); 13 C NMR 5.91 (C 3′ ), 19.44 (C 4′ ), 63.05 (C 5′ ), 115.76 (C 1′ ), 117.51 (C 2′ ); benzoyl: 128.90 (C ortho and C meta ), 133.23 (C para ), 133.50 (C ipso ) and 167.78 (C=O); cytosine ring: 97.12 (C 5 ), 145.33 (C 6 ), 153.97 (C 4 ), 163.51 (C 2 ); EI-MS 297 (M, 10.4), 280 (M-OH, 15.9), 266 (M-CH 2 OH, 10.1), 216 (6.7), 176 (6.9), 162 (4.8), 122 (7.3), 105 (100.0); HRMS calcd for C 16 , 5.74; N, 21.76. Found: C, 55.78; H, 5.94; N, 21.93 .
The E isomer 19 (250 mg, 0.84 mmol) was debenzoylated using the procedure described above to give compound 7 (132 mg, 81%). M.p. 218-220°C. UV λ max 296 nm (ε 12 900), 230 (ε 12 900), 205 (ε 14 900); IR 3370, 3310 and 3100 (OH and NH 2 ), 1670, 1630 and 1505 (cytosine ring and olefin), 1025 cm -1 (cyclopropane ring); 1 H NMR δ 1.22 (ddd, 1H, 2 J 8.5 Hz, 3 J trans 5.0 Hz, 4 J 2.5 Hz) and 1.56 (td, 1H, 2 (Z)-1-(2-hydroxymethylcyclopropylidenemethyl)thymine 8 and (E)-1-(2-hydroxymethylcyclopropylidenemethyl)thymine 9 A mixture of Z and E isomers 23 and 24 from the preceding experiment was used. DIBALH (1.0 M in cyclohexane, 15.0 ml, 15.0 mmol) was added dropwise into a stirred solution of 23 plus 24 (1.00 g, 4.0 mmol) in THF (80 ml) during 15 min at 0°C under N 2 . Stirring was continued at 0°C for 4 h. The reaction was quenched by adding MeOH : H 2 O (2 : 1, 30 ml) at 0°C and the mixture was then stirred at room temperature for 16 h. The resultant gel was filtered off and washed with CH 2 Cl 2 : MeOH (9 : 1, 5×60 ml) with the aid of a sonicator. The combined filtrate and washings were evaporated and the residue was chromatographed on a silica gel column using hexane : THF (3 : 2×1 : 1 containing 0.5% MeOH) to give Z isomer 9 (100 mg, 12%) and E isomer 8 (330 mg, 40%). 
Materials and Methods: Virology
The antiviral assays employed were described in detail previously (Qiu et al., 1998) . Briefly, the following assays were performed: HCMV plaque and yield reduction assays in HFF cell culture with the Towne strain of virus, as well as CPE inhibition, ESV-1 ELISA assay with BSC-2 cells, and plaque reduction with HSV-1, HSV-2, VZV and MCMV in HFF or MEF cells (MCMV). HSV-1 and HSV-2 were also assayed in Vero cells by plaque reduction and by CPE inhibition in HFF cells. The HHV-6 strain GS was assayed by ELISA in HSB-2 cell culture, EBV by immunofluorescence assay in Daudi cells and by DNA hybridization in H-1 cells. HBV assays were performed with the transfected HepG-2 2.2.15 cell line. Anti-HIV-1 activity was determined with strain IIIB in CEM-SS cell culture by supernatant reverse transcriptase assay.
The cytotoxicity studies employed the respective unin- 
Results
Synthesis
The Z-and E-2,6-diaminopurine analogues 4a and 4b were obtained by ammonolysis of 2-amino-6-chloropurine derivatives 3a and 3b with NH 3 in methanol at 100°C in an autoclave (92-93% yield) after chromatography (Fig. 3) . In a similar fashion, the 2-amino-6-cyclopropylaminopurine analogue 5a was obtained in 96% yield by refluxing 3a with an excess of cyclopropylamine in ethanol.
Direct alkylation of cytosine with dibromocyclopropane carboxylic esters 12 and 13 did not give a good yield of alkylation/elimination products. However, reaction of N 4acetylcytosine (14) with 12 and 13 readily furnished, after deprotection, a mixture of methyl esters 15 and 16 in 46.8% yield and a Z/E ratio of 7 : 3 (Fig. 4) . To remove the Nacetyl function, the crude product was subjected to methanolysis at 50°C which led to a transesterification. Crystallization from ethanol gave pure Z isomer 15 in 27% yield. The mother liquor afforded a mixture of 15 and 16 (11.3 %) in a ratio of 1 : 2. Because both isomers 6 and 7 were necessary for biological investigation, the latter mixture was reduced to give crude methylenecyclopropane alcohols 6 and 7, which were inseparable by chromatography. Therefore, a small portion of the crude product was converted to the N 4 -dimethylaminomethylene derivatives (Zemlicka & Holy′ , 1967) . Although the latter were separated by TLC on an analytical scale, an attempted preparative resolution was not successful owing to a partial loss of the less stable N 4 -dimethylaminomethylene group (Holy′& Zemlicka, 1969) during chromatography. A mixture of compounds 6 and 7 was then benzoylated with benzoic anhydride in ethanol (Otter & Fox, 1968) to give the more stable N 4 -benzoyl derivatives. Separation by column chromatography on silica gel furnished a mixture of N,Odibenzoyl derivatives 17 (20%) followed by Z-and E-N 4benzoyl isomers 18 and 19 in 20.7 and 41.4% yield, respectively. Compound 18 was readily debenzoylated with NH 3 in methanol to give syncytol (6) (77% yield). The E analogue 7 was obtained in a similar fashion from 19 in 81% yield.
Because direct alkylation of thymine gave a complex mixture of products a different approach was adopted. Bis-2,4-O-trimethylsilyl-5-methylpyrimidine 20 (Fig. 5 ) was alkylated with dibromoesters 12 and 13 by a prolonged reflux in acetonitrile (72-110 h) to give a mixture of bromoesters 21 and 22 in 70-79% yield. Both isomers could be resolved by chromatography but their preparative separation was not attempted. The mixture of isomers was con- verted to unsaturated Z and E esters 23 and 24 by reaction with K 2 CO 3 in DMF at 100°C for 3 h. The Z isomer 23 (R=Et) was obtained by chromatography in 29% yield whereas the E isomer 24 (approximately 28% yield) was cross-contaminated with 23 and also contained some methyl esters resulting from a transesterification with methanol used in the work-up of the reaction mixture. This crude mixture (Z/E and ethyl/methyl ester ratios estimated by 1 H NMR were 36 : 64 and 40 : 60, respectively) was reduced with DIBALH in THF to give, after chromatographic separation, synthymol (8) (12%) and the respective E isomer 9 (40%).
As observed before with purine methylenecyclopropanes (Qiu et al., 1998) , polarity plays a crucial role in separation of Z-and E-methylenecyclopropane pyrimidine derivatives by chromatography. Thus, polar cytosine analogues 6 and 7 needed derivatization (N 4 -benzoylation) for a successful chromatographic separation but a mixture of isomers 8 and 7 comprising a less polar thymine moiety was separated directly.
NMR spectra and assignment of E/Z isomers
The chemical shifts of heterocyclic protons were of importance for assignment of the Z and E isomeric structures 6, 7 and 8, 9. Thus, similar to purine H 8 and H 2 signals (Qiu et al., 1998) , a downfield shift of the H 6 relative to the E isomers 7, 8 and 19 was noted in pyrimidine Z analogues 6, 8 and 18 but the H 5 was little influenced (Table 1) .
However, the ∆δH 6 of 6 and 7 was smaller. It is recognized that the rotational barrier of the pyrimidine base in nucleosides is higher than that of purine (Danyluk, 1979) . In pyrimidine nucleosides of an anti conformation (Zemlicka & Horwitz, 1975) , it is the H 6 that is more deshielded relative to the H 5 as well as H 6 of models with a free rotation of the heterocyclic base.
The H 6 chemical shift in E-carboxylic ester 16 is located downfield from that of the corresponding Z isomer 15, thus following a trend observed for the H 8 chemical shifts of purine analogues (Qiu et al., 1998) . By contrast, the H 6 of the Z isomer of the thymine ester 23 is situated downfield from that of the E isomer 24 but the ∆δH 6 is small.
The protons of the hydroxymethyl group (H 5′ ) in pyrimidine E analogues 7, 9 and 19 are magnetically equivalent whereas those of the Z isomers 6, 8 and 18 are not.
All this data followed the pattern established previously (Qiu et al., 1998) allowing the confirmation of the Z and E isomeric structures of both pairs of pyrimidine analogues 6, 7 and 8, 9.
Antiviral activity
The antiviral testing of analogues 4a, 4b, 5a, 6, 7, 8 and 9 gave the following results. The 2,6-diaminopurine analogue 4a was a less effective inhibitor of replication of HCMV than synadenol 1 or synguanol 2 (Qiu et al., 1998) in all assays. It exhibited an EC 50 of 23.7 and an IC 90 of 18 µM, in plaque and yield reduction assays, respectively, and it also inhibited the replication of HCMV with an EC 50 of 11.2 µM ( Table 2) . The E isomer 4b was inactive. By contrast, 2-amino-6-cyclopropylaminopurine derivative 5 was a very potent inhibitor of HCMV, comparable to synadenol 1 and synguanol 2, with an EC 50 of 0.4 µM in plaque reduction, 2 µM in CPE inhibition and an EC 90 of 1 µM in yield reduction assays. Analogue 5 was also a very potent inhibitor of MCMV (EC 50 0.4 µM) indicating suitability for in vivo tests in a murine model of CMV infection. As already mentioned, purine nucleoside analogues carrying 2-amino and 6-cyclo-propylamino function, 10a and 10b, exhibited a high antiviral potency Van et al., 1996) . Analogue 10a was converted in cells to carbovir triphosphate by a new metabolic pathway utilizing adenosine phosphotransferase and a cytosolic deaminating enzyme distinct from AMP deaminase . It is then possible that 5 is a prodrug of synguanol 1 but further studies are necessary to clarify this point. From the pyrimidine group of analogues only syncytol 6 was effective against HCMV with an EC 50 of 28.5 µM in plaque reduction, 3.4 µM in CPE inhibition and an EC 90 of 16 µM in yield reduction assays. Somewhat surprisingly, the 2,6-diaminopurine analogue 4a was much more effective against MCMV than HCMV with an EC 50 of 0.6 µM, but the opposite situation was encountered in the case of syncytol 6 (EC 50 52.3 µM). Synthymol 8 was the most potent analogue against HSV-1 in an ELISA assay in BSC-2 cells (EC 50 2 µM) but it was ineffective in other assays and also against HSV-2 (Table 3 ). The 2-amino-6-cyclopropylaminopurine analogue 5 was a moderate inhibitor of replication of both viruses regardless of the type of assay (EC 50 15 to 74 µM). The rest of the tested analogues were without any significant effect.
Draanen
More interesting activity levels were detected with other herpesviruses such as EBV and VZV (Table 4 ). Most surprisingly, syncytol 6 and the E isomer 7 were equipotent against EBV in an immunofluorescence assay with Daudi *Plaque reduction (PR), yield reduction and CPE inhibition assays were performed in duplicate or triplicate as described (Qiu et al., 1998) .
Results from plaque assays are reported as EC 50 values, those for yield reduction experiments as EC 90 values. NT, Not tested. †Visual cytotoxicity was scored on stationary HFF and MEF cells at the time of HCMV and MCMV plaque enumeration in cells not affected by the virus. Cytotoxicities of IC 50 >100 µM were also calculated by neutral red uptake and in rapidly proliferating HFF cells. Inhibition of KB cell growth was determined as described (Qiu et al., 1998) in quadruplicate assays. ‡Averages ±SD derived from 108 and 33 experiments, respectively. Table 2 . †For cytotoxicity in HFF cells see Table 2 . ‡Cytotoxicity was determined in CEM cells. §The assay was performed as described (Qiu et al., 1998) . Commercial antibody (Dako) that reacts with all major glycoproteins in the viral envelope and at least one core protein was employed. ¶Ganciclovir. ||Acyclovir. cells (EC 50 <0.41 µM). Nevertheless, the Z isomer 6 surpassed compound 7 (EC 50 >50 µM) in a DNA hybridization assay in both Daudi and H-1 cells with EC 50 values of 19.7 and 2.5 µM, respectively. Synthymol 8 was also potent against EBV in Daudi cells (EC 50 1.3 µM) but less so in H-1 culture. It should be noted that a significant anti-EBV effect (EC 50 3 µM) was noted (Qiu et al., 1998) in an immunofluorescence assay (Daudi cells) with the E isomer of synadenol 1. The 2,6-diaminopurine analogue 4a had an EC 50 of 6.9 µM in Daudi cells whereas in H-1 cell culture its potency (EC 50 1.5 µM) was superior to that of syncytol (6, EC 50 2.5 µM). The 2-amino-6-cyclopropylaminopurine analogue 5 in Daudi cell culture was somewhat lower in potency (EC 50 11.8 µM) than synguanol 2 (EC 50 5.6 µM; Qiu et al., 1998) but this does not exclude the possibility that 5 can function as a prodrug of 2. In VZV assays, syncytol 6 was the most potent, with an EC 50 of 3.6 µM. In contrast, all tested analogues were without significant effect on HHV-6.
The most efective inhibitor of replication of HBV in 2.2.15 cells was the 2-amino-6-cyclopropylaminopurine analogue 5 (EC 50 2 µM) followed by 2,6-diaminopurine derivative 4a (EC 50 10 µM, Table 5 ). In this case, the activity of 5 equalled that of synadenol 1 but it was superior to synguanol 2 (EC 50 10 µM; Qiu et al., 1998) . As in the pre- Table 2 . NT, Not tested. †Slot-blot assay (Qiu et al., 1998) . ‡Immunofluorescence assay (Qiu et al., 1998) . §For cytotoxicity see Table 2 . ¶IC 50 27.9 µM in rapidly proliferating Daudi cells.
||DNA hybridization experiments gave EC 50 of 19.7 µM for 6 and >50 µM for 7. **Ganciclovir. † †Acyclovir. ‡ ‡Foscarnet. Qiu et al. (1998) . NT, Not tested. †Cytotoxicity was determined in CEM cells (Table 3 ) and by the effect of compounds on mitochondrial DNA (mtDNA) synthesis. The EC 50 of zalcitabine (ddC) was 10 µM in the CEM cells assay. Qiu et al. (1998) . NT, Not tested. †Visual cytotoxicity.
vious series of analogues, the anti-HIV effect was seen only at a lower virus load with 4a, 6 and 7 (Table 6) . At higher levels of virus no activity was observed. The E isomers 4b and 9 lacked any antiviral activity. The tested compounds were found to be non-cytotoxic (IC 50 >100 µM) in uninfected cell cultures (in H-1 cells the IC 50 was >50 µM) and in KB cells (Table 2) . A lack of cytotoxicity was also observed in a neutral red uptake assay in rapidly proliferating HFF cells. Analogue 5 displayed moderate cytotoxicity in rapidly proliferating Daudi cells (IC 50 27.9 µM). A similar effect was noted with synguanol 2 (IC 50 12.9 µM; Qiu et al., 1998) . This result may provide additional support for a metabolic relationship between these analogues. None of the tested compounds displayed any long-term (mitochondrial) toxicity (Parker & Cheng, 1994) determined in CEM cells within the stated limits (IC 50 of >50 or >100 µM, Table 5 ).
Syncytol 6 and E isomer 7 were devoid of significant anti-tumour activity as determined by a clonogenic assay in murine leukaemia L1210 cell culture (IC 50 50 and 85 µM, respectively) and by disk diffusion assay (Phadtare et al., 1991) in mouse solid tumour cell lines C-38 and M-17/Adr and human tumour H-116.
Unlike synadenol 1 (Qiu et al., 1998) , compound 4a was inert toward adenosine deaminase from calf intestine and AMP deaminase from Aspergillus sp.
